We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Gaithersburg, Md.-based Emergent BioSolutions has struck a five-year deal with Providence Therapeutics to help manufacture the Canadian company’s COVID-19 vaccine candidate. Read More
The doctor submitted the results to ClinicalTrials.gov one day after receiving the warning letter, sidestepping a potential fine of at least $10,000 for every day he was in noncompliance. Read More
A federal judge has denied Teva Pharmaceuticals’ motion to dismiss a lawsuit alleging the Israeli drugmaker paid kickbacks to charitable foundations to subsidize Medicare patients’ out-of-pocket payments for its multiple sclerosis drug Copaxone (glatiramer). Read More
A third of the indications for cancer drugs that failed their confirmatory trials after accelerated approval remain on the label for years, with some even getting high endorsements from an alliance of 31 leading oncology centers. Read More
Acting FDA Commissioner Janet Woodcock has sent a letter to the U.S. Patent and Trademark Office (PTO), asking the office to investigate drugmakers’ use of “patent thickets” and other anticompetitive patent practices. Read More
Two outgoing vaccine experts at the FDA as well as experts from the World Health Organization (WHO) are arguing that providing COVID-19 booster shots to the general public isn’t warranted at this time. Read More
Endo International has agreed to pay $50 million to settle lawsuits filed by New York state and two of its biggest counties, Nassau and Suffolk, alleging the Dublin, Ireland, distributer helped fuel the nation’s opioid epidemic. Read More